Companies: 10,795·Total market cap: $144.5T
STERIS plc

STERIS plc

STENYSEHealthcare● Active
$210.03
$-2.32(-1.09%)
Market Cap$20.5B
P/E Ratio
52W High$269.44
52W Low$195.14
Overview

STERIS plc (STE) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

STE · free cash flow · updated Jun 8, 2026

Core FCF metrics

Free cash flow was $972.4M for FY2026 (fiscal year ending 2026-03-31), up 25.0% year-over-year The FCF margin was 16.4%. Five-year CAGR stands at +16.6%.

FY2026 Free Cash Flow$972.4M▲ +25.0% YoY
Trailing 12M (TTM)$972.4Mtrailing 4 quarters sum
FCF Margin16.4%$972.4M ÷ revenue
3-Year CAGR+35.0%FY2023 → FY2026
5-Year CAGR+16.6%FY2021 → FY2026
FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

Positive FCFNegative FCF
Free Cash Flow
YoY Growth %
ste free cash flow history · ste free cash flow chart · ste free cash flow growth rate · ste free cash flow last 10 years

Annual free cash flow data

Fiscal YearFree Cash FlowYoY ChangeFCF Margin
FY2026Latest$972.4M▲ +25.0%16.4%
FY2025$778.0M▲ +26.9%14.3%
FY2024$612.9M▲ +55.2%11.9%
FY2023$395.0M▼ 0.6%8.7%
FY2022$397.2M▼ 11.8%9.4%
FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP
ste free cash flow 2026 · ste free cash flow 2025 · ste free cash flow 2024 · ste operating cash flow

FCF valuation metrics

STERIS plc (STE) trades at a FCF yield of 4.72% and a price-to-free-cash-flow ratio of 21.2x. FCF per share stands at $9.90, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)
4.72%
Free Cash Flow ÷ Market Cap
per FMP freeCashFlowYieldTTM definition
FCF per Share (TTM)
$9.90
TTM FCF ÷ Shares Outstanding
Price / FCF
x21.2
Share Price ÷ FCF per Share
EV / FCF (TTM)
x22.9
Enterprise Value basis
Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31
ste price to free cash flow · ste free cash flow yield · ste free cash flow per share · ste price to cash flow ratio

Cash flow statement summary

For FY2026, STERIS plc generated $1.34B in operating cash flow and spent 369M in capital expenditures, yielding $972.4M in free cash flow.

Operating Activities
+$1.34B
Cash from core business operations
2026-03-31
Investing Activities
−$512.5M
CapEx, acquisitions & investments
2026-03-31
Financing Activities
−$568.2M
Buybacks, dividends & debt
2026-03-31
FCF FormulaOperating CF ($1.34B) − |CapEx| (369M) = FCF ($972.4M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement
ste cash flow statement · ste cash flow statement 2026 · ste operating cash flow · ste cash flow from operations

Free cash flow vs peers (Healthcare)

#CompanyFree Cash FlowYoY
#1
STERIS plc
STERIS plcYOU
STE
$972.4M+25.0%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$19.70B-0.7%
#3
AbbVie Inc.
AbbVie Inc.
ABBV
$17.82B-0.1%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$16.07B-22.4%
#5
Eli Lilly and Company
Eli Lilly and Company
LLY
$8.97B+2065.6%
Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

STERIS plc (STE) reported free cash flow of $972.4M for FY2026 (fiscal year ending 2026-03-31), up 25.0% year-over-year. The FCF margin was 16.4%.

Based on available data, STERIS plc has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $972.4M in FY2026. The 5-year CAGR stands at +16.6%.

STERIS plc's FCF yield is 4.72% and price-to-FCF ratio is 21.2x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Frequently asked questions

STE free cash flow · 8 questions

STERIS plc free cash flow was $972.4M for FY2026, up 25.0% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $972.4M.

STE free cash flowSTE FCFSTE FCF 2026STE free cash flow TTM

Source: FMP /cash-flow-statement · US GAAP · STERIS plc · STERIS plc SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026